Apperton
FranceWho owns Apperton?
Apperton is a French Healthcare company, currently owned by BNP Paribas Developpement since 2025 and 2 other investors. It changed hands in 2025, when Ekkio Capital sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by BNP Paribas Developpement, Evolem and Garibaldi Participations since 2025.
- ·Best return: 6.7x MOIC by Ekkio Capital (2025 exit).
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Ekkio Capital sold Apperton to Evolem in 2025 after 10 years.
More from Garibaldi Participations SCR
Other portfolio companies in the same fund.
More PE-backed in Industrials
Comparable industrials deals from other GPs.
UK
Germany
Finland
USQuestions
Who owns Apperton?
Apperton is currently owned by BNP Paribas Developpement, Evolem and 1 other, through Garibaldi Participations SCR, since 2025.
When did BNP Paribas Developpement and 2 others acquire Apperton?
BNP Paribas Developpement and 2 others acquired Apperton in 2025.
Who did Apperton sell to?
Ekkio Capital sold Apperton to Evolem in 2025 (Secondary), 6.7x return.
Who has owned Apperton over time?
Apperton has been through 4 private-equity ownership periods: Ekkio Capital · via Ekkio Capital IV · 2015–2025 · sold to Evolem · (Secondary) · 6.7x; BNP Paribas Developpement · via BNP Paribas Developpement · since 2025; Evolem · via Evolem Platform · 2025–2025; Garibaldi Participations · via Garibaldi Participations SCR · 2025–2025.